Dr Victoria Menghetti Smith, PSYD | |
3510 N Lake Creek Dr, Wilson, WY 83014-9695 | |
(307) 699-3996 | |
Not Available |
Full Name | Dr Victoria Menghetti Smith |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 3510 N Lake Creek Dr, Wilson, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558760207 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 650 (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Victoria Menghetti Smith, PSYD Po Box 6398, Jackson, WY 83002-6398 Ph: (307) 699-3996 | Dr Victoria Menghetti Smith, PSYD 3510 N Lake Creek Dr, Wilson, WY 83014-9695 Ph: (307) 699-3996 |
News Archive
Parkinson's disease (PD) is a progressive neurological condition. At present, it is usually diagnosed only when motor features are present. Hence, there is a need to develop objective and measurable biomarkers to improve PD diagnostics during its earlier stage, prior to its motor onset. In this pilot study, researchers identified and tested the first blood-based circulating microRNA (miRNA) biomarkers for PD.
Data from one of the largest national registries of transcatheter aortic valve replacement (TAVR) patients shows that although women are more likely to experience vascular complications in the hospital, their one-year survival rate is more favorable than men.
Noting that the organization's research "has touched the lives of virtually every adult cancer patient in this nation," the National Cancer Institute has renewed the Southwest Oncology Group's operating grants for six years, with a total funding package over that period expected to exceed $120 million.
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
With the early onset of flu season coinciding with the start of school this year, concern about the flu, and in particular the H1N1 strain of the flu, is growing among parents. Experts from The Children's Hospital in Denver, Colo., can offer a pediatric perspective on all types of flu, including H1N1, also known as swine flu.
› Verified 7 days ago
Miss Laura Lea Perez, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3850 North Wilderness Dr., Wilson, WY 83014 Phone: 307-733-2810 Fax: 307-733-8462 |